Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from InhaleRx Limited ( (AU:IRX) ).
InhaleRx Limited has announced the quotation of 17,100,000 fully paid ordinary securities on the ASX, as part of a previously disclosed transaction. This move is expected to enhance the company’s financial flexibility and potentially strengthen its market position by increasing its capital base, thereby benefiting stakeholders through improved operational capabilities.
More about InhaleRx Limited
InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and distribution of inhalation-based drug delivery systems. The company is engaged in creating innovative solutions for respiratory conditions and aims to enhance patient outcomes through advanced inhalation technologies.
Average Trading Volume: 257,221
Technical Sentiment Signal: Sell
Current Market Cap: A$5.92M
For an in-depth examination of IRX stock, go to TipRanks’ Overview page.